Mirazul (Phenylephrine Hydrochloride)

• Phenylephrine Hydrochloride is an alpha‑1 adrenergic agonist used in ophthalmology to induce mydriasis and vasoconstriction.
• Mydriasis for diagnostic eye examinations: enables thorough retinal and anterior segment evaluation.
• Ocular redness reduction: decreases conjunctival hyperemia and improves cosmetic appearance.
• Pre‑operative ocular preparation: provides pupil dilation and reduces bleeding risk during intra‑ocular surgery.

• Phenylephrine Hydrochloride acts as a selective α1‑adrenergic receptor agonist on the iris dilator muscle and conjunctival vessels. Activation of these receptors triggers smooth‑muscle contraction, leading to dilation of the pupil (mydriasis) and vasoconstriction of conjunctival capillaries, which reduces redness and limits ocular blood flow. The effect is localized to the eye when administered topically. The response typically begins within minutes and lasts for up to two hours, depending on concentration and individual sensitivity.

Phenylephrine Hydrochloride may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects

• Transient ocular burning or stinging.
• Mild conjunctival hyperemia.
• Temporary blurred vision.
• Mild headache.
• Slight increase in intra‑ocular pressure in susceptible individuals.
• Mild ocular discomfort.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis).
• Sustained mydriasis leading to photophobia.
• Acute angle‑closure glaucoma.
• Systemic hypertension.
• Cardiac arrhythmia.
• Severe ocular pain or corneal edema.

• When using Mirazul, consider the following precautions to ensure safe administration.
• Assess intra‑ocular pressure before use: avoid in patients with narrow‑angle glaucoma.
• Avoid use in children unless directed: pediatric safety not established.
• Monitor for systemic absorption: patients with cardiovascular disease should be observed.
• Do not combine with other mydriatics: may cause excessive dilation.
• Store below 25°C: keep in original container, protect from moisture and light.

Phenylephrine Hydrochloride can interact with other medications; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Concurrent use with systemic sympathomimetics: may cause excessive hypertension.
• Combination with MAO inhibitors: risk of hypertensive crisis.
• Use with other ocular vasoconstrictors: may increase risk of ischemia.

Moderate Interactions (Monitor Closely)

• Co‑administration with beta‑blocker eye drops: may alter pupil response.
• Use with topical anesthetics: may enhance ocular irritation.
• Concurrent use of antihistamine eye drops: may affect efficacy.